First National Corp T2 Biosystems, Inc. Transaction History

First National Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Jul 30, 2019	SELL	$1.47 - $3.16 $294 - $632	-200 Closed	0 $0
Q1 2019 Jun 12, 2019	BUY	$2.56 - $4.48 $512 - $896	200 New	200 $2,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.53M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

Stay updated on First National Corp with notifications on news.